Medicare Enrolled

Dr. Shahe Vartivarian, M.D.

Optician · Houston, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
7777 SOUTHWEST FWY, Houston, TX 77074
7133399949
Registered in NPPES since 2006
NPI: 1235233651 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vartivarian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vartivarian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Vartivarian

Dr. Shahe Vartivarian is an optician specialist in Houston, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Vartivarian performed 5,104 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Vartivarian received a total of $9,382 from 29 pharmaceutical and/or device companies across 504 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Vartivarian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 15% volume in TX $9,382 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
5,104
Medicare services
Top 15% in TX for optician
Not available
Unique patients (not deduplicated)
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Injection, cefepime hydrochloride, 500 mg 2,952 $1 $45
Refilling and maintenance of portable pump
This service involves refilling and performing maintenance on a portable pump.
833 $102 $375
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
674 $71 $130
Oxygen chamber therapy management
This code covers the professional management and oversight of a patient undergoing oxygen chamber therapy. It involves monitoring the patient's response and adjusting the treatment plan as needed.
197 $84 $445
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
193 $64 $130
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
101 $40 $72
Skin and tissue removal, 20 sq cm or less
This procedure involves the surgical excision of skin and underlying tissue from an area measuring 20 square centimeters or smaller.
88 $47 $230
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
31 $91 $199
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
23 $135 $325
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
12 $100 $247
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,382
Total received (2018-2024)
Avg $1,340/year across 7 years
Top 18% in TX for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
504
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,463
2023
$1,181
2022
$1,573
2021
$1,530
2020
$1,179
2019
$1,259
2018
$1,196

Payments by company (2024)

ABBVIE INC.
$334
Cumberland Pharmaceuticals, Inc.
$182
Merck Sharp & Dohme LLC
$168
ViiV Healthcare Company
$155
Gilead Sciences, Inc.
$154
Melinta Therapeutics, LLC
$119
Paratek Pharmaceuticals, Inc.
$116
Insmed, Inc.
$87
EMD Serono, Inc.
$44
AIMMUNE THERAPEUTICS, INC.
$38
Shionogi Inc
$30
Inari Medical, Inc.
$19
La Jolla Pharmaceutical Company
$17
Top 3 companies account for 46.8% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme Corporation
$1,064
Paratek Pharmaceuticals, Inc.
$873
Shionogi Inc
$772
ViiV Healthcare Company
$728
Gilead Sciences, Inc.
$652
AbbVie Inc.
$640
Cumberland Pharmaceuticals, Inc.
$611
ABBVIE INC.
$606
Insmed, Inc.
$512
Allergan Inc.
$505
Astellas Pharma US Inc
$419
Merck Sharp & Dohme LLC
$411
Allergan, Inc.
$334
EMD Serono, Inc.
$332
Janssen Biotech, Inc.
$187
Melinta Therapeutics, LLC
$173
Osiris Therapeutics Inc.
$98
Melinta Therapeutics, Inc.
$88
Mayne Pharma Inc.
$57
Ferring Pharmaceuticals Inc.
$49
CIPLA USA INC.
$47
MAYNE PHARMA INC.
$44
AIMMUNE THERAPEUTICS, INC.
$38
Integra LifeSciences Corporation
$38
La Jolla Pharmaceutical Company
$36
Nabriva Therapeutics, plc
$22
Inari Medical, Inc.
$19
Smith & Nephew, Inc.
$13
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$13
Top 3 companies account for 28.9% of all-time payments
Associated products mentioned in payments ›
AVYCAZ · Arikayce · Baxdela · CABENUVA · CRESEMBA · DALVANCE · DELSTRIGO · DIFICID · DORYX · DOVATO · FLOWTRIEVER CATHETER · Fetroja · GRAFIX/GRAFIXPL/STRAVIX · ISENTRESS · JULUCA · Kimyrsa · LEXISCAN · MAVYRET · NUZYRA · OMNIGRAFT · PIFELTRO · PREZCOBIX · PREZISTA · REBYOTA · RUKOBIA · S · SEROSTIM · SYMTUZA · Santyl · Serostim · Symtuza · TEFLARO · VIBATIV · VOWST · Vabomere · Vibativ · XACDURO · XERAVA · XIFAXAN · Xenleta · ZEMDRI (PLAZOMICIN) · ZERBAXA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an optician specialist in Houston?
Compare opticians in the Houston area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians in nearby ZIP areas
515
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
WEST OAKS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Vartivarian is a clinical cardiology specialist, with above-average Medicare volume (top 15% in TX), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Vartivarian experienced with injection, cefepime hydrochloride, 500 mg?
Based on Medicare claims data, Dr. Vartivarian performed 2,952 injection, cefepime hydrochloride, 500 mg services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Vartivarian receive payments from pharmaceutical companies?
Yes. Dr. Vartivarian received a total of $9,382 from 29 companies across 504 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vartivarian's costs compare to other opticians in Houston?
Dr. Vartivarian's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vartivarian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →